Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study I
Public ClinicalTrials.gov record NCT02677298. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Randomized Double Blind Phase 3 Study to Assess the Efficacy and Safety of BoNT/A-DP in the Treatment of Glabellar Lines in Comparison With Placebo, Followed by an Open Label Extension Study
Study identification
- NCT ID
- NCT02677298
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Croma-Pharma GmbH
- Industry
- Enrollment
- 784 participants
Conditions and interventions
Conditions
Interventions
- Botulinum Toxin A Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 1, 2016
- Primary completion
- Nov 22, 2016
- Completion
- Nov 15, 2017
- Last update posted
- Mar 18, 2025
2016 – 2017
United States locations
- U.S. sites
- 9
- U.S. states
- 8
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Total Skin And Beauty Dermatology Center, Pc | Birmingham | Alabama | 35205 | — |
| Clinical Testing of Beverly Hills | Encino | California | 91436 | — |
| Maas Clinic | San Francisco | California | 94115 | — |
| About Skin | Greenwood Village | Colorado | 80111 | — |
| DeNova Research | Chicago | Illinois | 60611 | — |
| Skin Specialists | Omaha | Nebraska | 68144 | — |
| Aesthetic Solutions | Chapel Hill | North Carolina | 27517 | — |
| Society Hill Dermatology | Philadelphia | Pennsylvania | 19104 | — |
| Tennessee Clinical Research Center | Nashville | Tennessee | 37215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02677298, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 18, 2025 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02677298 live on ClinicalTrials.gov.